Viewing Study NCT02356796



Ignite Creation Date: 2024-05-06 @ 3:43 AM
Last Modification Date: 2024-10-26 @ 11:37 AM
Study NCT ID: NCT02356796
Status: COMPLETED
Last Update Posted: 2018-05-03
First Post: 2015-02-02

Brief Title: Chronic Pelvic Pain in Women - Conservative Group Treatment Compared to Standard Conservative Treatment
Sponsor: University Hospital of North Norway
Organization: University Hospital of North Norway

Study Overview

Official Title: Chronic Pelvic Pain in Women - Conservative Multidisciplinary Group Treatment Compared to Standard Conservative Treatment A Randomised Controlled Trial
Status: COMPLETED
Status Verified Date: 2018-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CPP
Brief Summary: The purpose of this study is to evaluate the effect of a multidisciplinary group based treatment compared to standard physiotherapy for women with chronic pelvic pain CPP The hypothesis is that multidisciplinary group based treatment is more effective than standard physiotherapy for women with CPP The participants will be randomized to one of two treatment arms and the treatment effect will be evaluated 12 months after start of intervention
Detailed Description: Background Chronic pelvic pain CPP is a common source of pain and reduced quality of life among women throughout the world CPP is a complex condition and the understanding of both etiology and effective treatment is limited The newestlatest clinical guidelines recommend a holistic and multidisciplinary treatment approach to this condition

In accordance with the guidelines a multidisciplinary group based treatment for women with CPP has been started at the University Hospital of North Norway The treatment is offered to patients who are considered to benefit from conservative treatment approach

Method To investigate the effect of a group based treatment compared to standard conservative treatment by physiotherapists in primary or secondary health care a randomized controlled trial will be conducted

Patients who are found eligible and consent to participate in the trial will be randomized to one of the two treatment options Data will be registered at baseline 3 6 and 12 months after start of treatment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None